Related references
Note: Only part of the references are listed.The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials
H. -f. Yuan et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Bone Density and Fractures in Autosomal Dominant Hyper IgE Syndrome
Kathryn J. Sowerwine et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Intravenous Zoledronic Acid Given Every 6 Months in Childhood Osteoporosis
Hooi Leng Ooi et al.
HORMONE RESEARCH IN PAEDIATRICS (2013)
Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis
Bhavna Padhye et al.
PEDIATRIC BLOOD & CANCER (2013)
Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome Molecular, Cellular, and Clinical Features From a French National Survey
Marie-Olivia Chandesris et al.
MEDICINE (2012)
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis
Peter J. Simm et al.
BONE (2011)
Zoledronic Acid Inhibits Macrophage SOCS3 Expression and Enhances Cytokine Production
Erica L. Scheller et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Bisphosphonates inhibit phosphorylation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signaling 3: implications for their effects on innate immune function and osteoclastogenesis
Jayne S. Reuben et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2011)
Bisphosphonates that lack a nitrogen-containing side chain do not cause osteonecrosis of the jaws, regardless of their effect on STAT3 phosphorylation and SOCS3 expression reply
Jayne S. Reuben
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2011)
Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups
Hong Jiao et al.
MOLECULAR IMMUNOLOGY (2008)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
Alendronate in the treatment of avascular necrosis of the hip
S Agarwala et al.
RHEUMATOLOGY (2002)
Share Paper
